Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 29, 2022
Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinomaPhongsaran Kimawaha, Raynoo Thanan, Apinya Jusakul, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|June 27, 2025
Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samplesWichit Taron, Wassana Jamnongkan, Cristakan Kamjanlard, et al.Cancer Science|May 14, 2016
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatmentMalinee Thanee, Watcharin Loilome, Anchalee Techasen, et al.Plos Neglected Tropical Diseases|October 21, 2015
Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in UrineChanika Worasith, Christine Kamamia, Anna Yakovleva, et al.Journal of Cancer|April 15, 2021
Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progressionNapat Armartmuntree, Apinya Jusakul, Chadamas Sakonsinsiri, et al.Acta Tropica|October 16, 2018
Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodGChompunoot Wangboon, Chanika Worasith, Raynoo Thanan, et al.Scientific Reports|April 8, 2025
Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinomaSutheemon Techa-Ay, Sasithorn Watcharadetwittaya, Raksawan Deenonpoe, et al.Frontiers in Public Health|February 28, 2022
Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With CholangiocarcinomaManida Suksawat, Jutarop Phetcharaburanin, Poramate Klanrit, et al.Journal of Proteome Research|July 17, 2019
Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma DiagnosisKassaporn Duangkumpha, Thomas Stoll, Jutarop Phetcharaburanin, et al.Plos One|August 20, 2019
Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosisKassaporn Duangkumpha, Thomas Stoll, Jutarop Phetcharaburanin, et al.Pageof 12